These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10788555)

  • 1. Is the human carcinogen arsenic carcinogenic to laboratory animals?
    Huff J; Chan P; Nyska A
    Toxicol Sci; 2000 May; 55(1):17-23. PubMed ID: 10788555
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in animal and human responses to carcinogenic metals.
    Gibb HJ; Farland WH
    Prog Clin Biol Res; 1992; 374():367-79. PubMed ID: 1620712
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer in experimental animals exposed to arsenic and arsenic compounds.
    Tokar EJ; Benbrahim-Tallaa L; Ward JM; Lunn R; Sams RL; Waalkes MP
    Crit Rev Toxicol; 2010 Nov; 40(10):912-27. PubMed ID: 20812815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ingested inorganic arsenic a "threshold" carcinogen?
    Abernathy CO; Chappell WR; Meek ME; Gibb H; Guo HR
    Fundam Appl Toxicol; 1996 Feb; 29(2):168-75. PubMed ID: 8742312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular metabolism and systemic toxicity of arsenic.
    Thomas DJ; Styblo M; Lin S
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):127-44. PubMed ID: 11601889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
    Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New in vitro approaches to explore cellular and molecular events related to carcinogenesis.
    Fimognari C; Nüsse M; Forti GC; Hrelia P
    Pharmacol Res; 2000 Apr; 41(4):385-90. PubMed ID: 10704260
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
    J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal ions in human cancer development.
    Tokar EJ; Benbrahim-Tallaa L; Waalkes MP
    Met Ions Life Sci; 2011; 8():375-401. PubMed ID: 21473387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enigma of arsenic carcinogenesis: role of metabolism.
    Goering PL; Aposhian HV; Mass MJ; Cebrián M; Beck BD; Waalkes MP
    Toxicol Sci; 1999 May; 49(1):5-14. PubMed ID: 10367337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human carcinogens and animal carcinogens].
    KURATSUNE K
    Fukuoka Igaku Zasshi; 1961 Nov; 52():783-7. PubMed ID: 14460701
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenic pesticides and environmental pollution: exposure, poisoning, hazards and recommendations.
    El-Bahnasawy MM; Mohammad Ael-H; Morsy TA
    J Egypt Soc Parasitol; 2013 Aug; 43(2):493-508. PubMed ID: 24260828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carcinogenic potential of cadmium, arsenic, and selenium and the associated public health and regulatory implications.
    Fan AM
    J Toxicol Sci; 1990 Dec; 15 Suppl 4():162-75. PubMed ID: 2100319
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data.
    Sielken RL; Stevenson DE
    Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708
    [No Abstract]   [Full Text] [Related]  

  • 15. Arsenic: in search of an antidote to a global poison.
    Mead MN
    Environ Health Perspect; 2005 Jun; 113(6):A378-86. PubMed ID: 15929879
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties.
    Chen C; Farland W
    Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541
    [No Abstract]   [Full Text] [Related]  

  • 18. Arsenic as an environmental toxicant and a therapeutic agent: Foe and friend.
    Xu Y; Tokar EJ; Pi J
    Toxicol Appl Pharmacol; 2021 Mar; 415():115438. PubMed ID: 33548274
    [No Abstract]   [Full Text] [Related]  

  • 19. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risks associated with arsenic in drinking water.
    Guo HR
    Environ Health Perspect; 2007 Jul; 115(7):A339-40; author reply A340-1. PubMed ID: 17637893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.